Literature DB >> 20652333

Low-dose continuous infusion of landiolol can reduce adrenergic response during tracheal intubation in elderly patients with cardiovascular disease.

Naoyuki Hirata1, Ryo Miyashita, Akihiko Watanabe, Michiaki Yamakage.   

Abstract

The objective of this study was to examine the effects of low-dose infusion of landiolol on hemodynamics during tracheal intubation in elderly patients with cardiovascular disease. The study population consisted of 30 patients with American Society of Anesthesiologists physical status II and III, aged 65-77 years, who were scheduled to undergo elective surgery under general anesthesia. Patients were randomly divided into two groups (n = 15 each): a control group, receiving normal saline, and a landiolol group, receiving landiolol at 30 μg/kg/min. After oxygenation, 1 μg/kg of fentanyl was injected intravenously, followed by continuous infusion of normal saline or landiolol for 5 min. General anesthesia was induced and maintained with target-controlled infusion of propofol at a blood concentration of 4 μg/ml and tracheal intubation was performed 3 min after vecuronium injection. Heart rate, blood pressure, and bispectral index were measured before and after tracheal intubation. Results showed that low-dose continuous infusion of landiolol is an effective and relatively safe method of preventing an intubation-induced adrenergic response in elderly patients with cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20652333     DOI: 10.1007/s00540-010-0975-5

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  8 in total

1.  Effects of landiolol on the cardiovascular response during tracheal extubation.

Authors:  Tetsuro Shirasaka; Tatsuma Iwasaki; Nobuko Hosokawa; Miki Komatsu; Toshiharu Kasaba; Mayumi Takasaki
Journal:  J Anesth       Date:  2008-08-07       Impact factor: 2.078

2.  The hemodynamic effects of landiolol, an ultra-short-acting beta1-selective blocker, on endotracheal intubation in patients with and without hypertension.

Authors:  Soichiro Sugiura; Sumihiko Seki; Kohji Hidaka; Miharu Masuoka; Hideaki Tsuchida
Journal:  Anesth Analg       Date:  2007-01       Impact factor: 5.108

3.  The short-acting beta1-adrenoceptor antagonists esmolol and landiolol suppress the bispectral index response to tracheal intubation during sevoflurane anesthesia.

Authors:  Yutaka Oda; Kiyonobu Nishikawa; Ichiro Hase; Akira Asada
Journal:  Anesth Analg       Date:  2005-03       Impact factor: 5.108

4.  Influence of landiolol on the dose requirement of propofol for induction of anesthesia.

Authors:  Daisuke Takizawa; Shigeru Saito; Eri Sato; Haruhiko Hiraoka; Fumio Kunimoto; Fumio Goto
Journal:  Fundam Clin Pharmacol       Date:  2005-10       Impact factor: 2.748

5.  Acute myocardial infarction in the elderly: differences by age.

Authors:  R H Mehta; S S Rathore; M J Radford; Y Wang; Y Wang; H M Krumholz
Journal:  J Am Coll Cardiol       Date:  2001-09       Impact factor: 24.094

6.  Hemodynamics and emergence profile of remifentanil versus fentanyl prospectively compared in a large population of surgical patients.

Authors:  R S Twersky; B Jamerson; D S Warner; L A Fleisher; S Hogue
Journal:  J Clin Anesth       Date:  2001-09       Impact factor: 9.452

7.  Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota, 1979 to 1994.

Authors:  Véronique L Roger; Steven J Jacobsen; Susan A Weston; Tauqir Y Goraya; Jill Killian; Guy S Reeder; Thomas E Kottke; Barbara P Yawn; Robert L Frye
Journal:  Ann Intern Med       Date:  2002-03-05       Impact factor: 25.391

Review 8.  The efficacy of landiolol for suppressing the hyperdynamic response following laryngoscopy and tracheal intubation: a systematic review.

Authors:  S Inoue; Y Tanaka; M Kawaguchi; H Furuya
Journal:  Anaesth Intensive Care       Date:  2009-11       Impact factor: 1.669

  8 in total
  1 in total

Review 1.  Landiolol: a review of its use in intraoperative and postoperative tachyarrhythmias.

Authors:  Greg L Plosker
Journal:  Drugs       Date:  2013-06       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.